Product Reports Resources Pricing Login Book a demo

Omniscient Neurotechnology

Biotech & Life Sciences · Sydney, Australia · Founded 2019

Enterprise grade clinical and research solutions applicable to a variety of brain-related disorders MoreLess

O8t.com, also known as Omniscient, operates in the healthcare technology sector, specifically focusing on neurology and brain health. The company's primary offering is a digital brain mapping solution, known as the connectome, which uses artificial intelligence (AI) and cloud computing to process vast quantities of neural data. This technology provides precise knowledge of a patient's unique brain networks, offering actionable insights for surgeons prior to life-changing surgeries.

The company's solutions are designed for a wide range of clients, including neurosurgeons, psychologists, and researchers. By providing a more robust understanding of the brain, Omniscient's tools aim to enhance the diagnosis and treatment of neurological conditions, thereby improving patient outcomes.

Omniscient's business model revolves around the development and sale of its brain mapping technology. The company generates revenue by partnering with healthcare institutions and professionals who utilize their technology for surgical planning and research purposes.

In addition to its commercial activities, Omniscient is also heavily involved in research and development. The company collaborates with top institutions worldwide to push the boundaries of brain health understanding and technology.

Keywords: Healthcare Technology, Neurology, Brain Mapping, Artificial Intelligence, Cloud Computing, Neurosurgery, Psychology, Research, Diagnosis, Treatment.

Company overview

Omniscient Neurotechnology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2019
Headquarters
Sydney, Australia
Employees
65
Open positions
11
Dealroom signal
80.3
client focusb2btechnologyArtificial IntelligencetechnologyBig DatatechnologyDeep Techsub industryBioTechnologysub industryMedical DevicesindustryHealthsectorPredictive AnalyticssectorBiotechnologysectorDrug DevelopmentsectorNeurologysectorTechbiosectorHard TechsectorDT and LS

Valuation & funding

Omniscient Neurotechnology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES DOther financing May 2026 $27M $445M Gina Rinehart · Will Vicars · Australian National Reconstruction Fund
SERIES COther financing Jun 2024 $58M $230M Will Vicars · Gina Rinehart
SERIES BOther financing Jul 2021 $26M $259M Gina Rinehart · Gretel Packer · Kerr Neilson · Will Vicars
SERIES AOther financing Jan 2020 $13M $52M Undisclosed
Showing 4 recorded eventsUnlock the complete deal history →

Growth signals

Omniscient Neurotechnology website traffic

Latest recorded traffic for Omniscient Neurotechnology is 32K monthly website visits, up 28% over the last three months. Omniscient Neurotechnology's team grew 12.1% over the past year.

Latest monthly visits32K 3-month web change+28% 1-year team growth+12.1%
Monthly website visits46 observations · Jan 2022–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Omniscient Neurotechnology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Omniscient Neurotechnology's talent

Book a demo to see the people
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

5 investors on Omniscient Neurotechnology's cap table

Sourced from Dealroom's funding and investor records.

Series A 4 investors entered at this stage
Gina Rinehart
Gretel Packer
Kerr Neilson
Will Vicars
Series B+ 1 investor entered at this stage
Australian National Reconstruction Fund

Global footprint

Where Omniscient Neurotechnology has talent and traffic

Workforce by country
7 countries with
team presence
🇺🇸 United States51.8%
🇨🇦 Canada23.2%
🇦🇺 Australia17.9%
🇧🇪 Belgium1.8%
🇨🇳 China1.8%
Top 5 of 7 shown

In the news

Latest news about Omniscient Neurotechnology

Recent press, funding announcements, and product moves mentioning Omniscient Neurotechnology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Omniscient Neurotechnology

An AI-synthesized read of the highest-engagement posts about Omniscient Neurotechnology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Omniscient Neurotechnology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.